DRD2 and metabolic disease: In our previous papers, it has been demonstrated that polymorphisms in insulin-induced gene 2 (INSIG2), LEP, FTO, dopamine D2 receptor (DRD2), and 5-HT receptor genes may contribute to the development of metabolic disorders in schizophrenia [25,26,27,28].